Lists of medical representatives Medicines for the year 2016
Communication Italian Drug Agency
With effect from 2017 it will be implemented a new system that will allow sending Pharmaceutical Companies, pursuant to art. 122, paragraph 1, of the d. lgs. 219/2006, the lists of medical representatives of the drug written directly on the new Front End of 'AIFA.
For the transmission of data relating to 2016, taking into account the exceptional nature of this phase of implementation of the new Agency's information systems, it will be provided an extension of time for submitting such list.
A new Communication Office Scientific Information - which will probably be published on the institutional portal around the middle of next January - will define exactly the terms of the extension and provide instructions for new input modes of data Scientific Informants on the Front End .
Companies, therefore, before proceeding to comply with the aforementioned legal requirement, are invited to wait for the next Office writer of communication, taking into account that the DATI_informatori@aifa.mailcert.it-mail address will not be usable.
